Mangoceuticals (NASDAQ:MGRX) Enters into Securities Purchase Agreements with Institutional Investors

Dallas, Texas, January 8, 2025 – Mangoceuticals, Inc. (NASDAQ:MGRX) recently disclosed in a Form 8-K filing with the Securities and Exchange Commission (SEC) that it has finalized Securities Purchase Agreements (SPAs) with institutional accredited investors. The agreements, effective on December 31, 2024, and subsequently on January 3, 2025 and January 6, 2025, involved the sale […]

Leave a Reply

Your email address will not be published.

Previous post **MedTech Acquisition Announces Leadership Transition and Salary Investment Program**
Next post Virpax Pharmaceuticals Receives Nasdaq Panel Decision, Granted Listing Continuation with Conditions